25 Result(s)

Article

Boekbesprekingen

L. O. M. J. Smithuis, J. R. B. J. Brouwers, J. C. Netelenbos… in Pharmaceutisch Weekblad (1980)

Article

Abstracts of papers

W. J. van Oort, J. J. M. Holthuis, E. J. de Vries… in Pharmaceutisch Weekblad (1983)

Article

Abstracts of papers Pharmaceutical and biomedical analysis meeting

R. Both-Miedema, E. H. J. M. Jansen, H. A. Claessens… in Pharmaceutisch Weekblad (1989)

Article

Abstracts of papers Clinical Pharmacological meeting

J. J. M. van Meyel, P. Smits, F. W. J. Gribnau… in Pharmaceutisch Weekblad (1989)

Article

Human pharmacokinetics of orally administered strontium

Pharmacokinetics of orally administered SrCl₂ (2.5 mmol), were studied in six healthy male volunteers. In the overall plasma concentration time (C-t) curves, two absorption phases were observed due to two dominan...

O. R. Leeuwenkamp, Dr. W. J. F. van der Vijgh… in Calcified Tissue International (1990)

Article

The effect of pamidronate on bone histomorphometry in osteoporotic patients

N. Bravenboer, P. Holzmann, J. C. Netelenbos… in Osteoporosis International (1996)

Article

Effects of continuously combined hormone replacement therapy on the biochemical markers of bone turnover

G. W. de Valk-de Roo, J. C. Netelenbos, E. Peters-Muller… in Osteoporosis International (1996)

Article

A test parameter representative for bioavailability of calcium and strontium in rats: Effect of intervention

R. Barto, A. J. A. M. Sips, M. ten Bolscher, J. C. Netelenbos… in Osteoporosis International (1996)

Article

The value of measuring a single biochemical bone marker in the prediction of bone mineral density

G. W. de Valk-de Roo, J. C. Netelenbos, A. Nicolaas… in Osteoporosis International (1996)

Article

The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: Results of three years of treatment

The purpose of this open, prospective, controlled, randomized trial was to study the effect of intermittent, cyclic etidronate on the bone mass of osteoporotic postmenopausal women with or without fractures. E...

M. L. M. Montessori, W. H. Scheele, J. C. Netelenbos… in Osteoporosis International (1997)

Article

Bone Histomorphometric Evaluation of Pamidronate Treatment in Clinically Manifest Osteoporosis

The effect of pamidronate therapy on bone histology was studied in patients with osteoporosis with at least one vertebral fracture in a randomized, double-masked, placebo-controlled, multi-center trial. Patie...

N. Bravenboer, S. E. Papapoulos, P. Holzmann, N. A. T. Hamdy… in Osteoporosis International (1999)

Article

Camurati–Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family

We report on a 46-year-old mother of Moroccan origin, suffering mainly from painful, swollen legs, and her 26-year-old son who had experienced intense pain in his legs, without fever, for approximately 3 years...

S. Simsek, K. Janssens, M. L. Kwee, W. Van Hul, J. Veenstra… in Osteoporosis International (2005)

Article

Spine radiographs to improve the identification of women at high risk for fractures

In women older than 60 years with clinical risk factors for osteoporosis but without osteoporosis based on bone mineral density (T-score ≥ −2.5), a systematic survey with X-rays of the spine identified previously...

J. C. Netelenbos, W. F. Lems, P. P. Geusens, H. J. Verhaar… in Osteoporosis International (2009)

Article

Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women

We examined variations in proportions of hip fractures and major fractures among postmenopausal women using the Global Longitudinal Study of Osteoporosis in Women (GLOW). The proportion of major fractures that...

J. Pfeilschifter, C. Cooper, N. B. Watts, J. Flahive… in Osteoporosis International (2012)

Article

Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women

Among 50,461 postmenopausal women, 1,822 fractures occurred (57% minor non-hip, non-vertebral [NHNV], 26% major NHNV, 10% spine, 7% hip) over 1 year. Spine fractures had the greatest detrimental effect on EQ-5...

C. Roux, A. Wyman, F. H. Hooven, S. H. Gehlbach, J. D. Adachi… in Osteoporosis International (2012)

Article

Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

We evaluated healthcare utilization associated with treating fracture types in >51,000 women aged ≥55 years. Over the course of 1 year, there were five times more non-hip, non-spine fractures than hip or spine...

G. Ioannidis, J. Flahive, L. Pickard, A. Papaioannou… in Osteoporosis International (2013)

Article

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study

Accurate patient risk perception of adverse health events promotes greater autonomy over, and motivation towards, health-related lifestyles.

C. L. Gregson, E. M. Dennison, J. E. Compston, S. Adami… in Osteoporosis International (2014)